News from tb alliance A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Aug 14, 2019, 12:52 ET FDA Approves New Treatment for Highly Drug-Resistant Forms of Tuberculosis

Pretomanid, a novel compound developed by the non-profit organization TB Alliance, was approved by the U.S. Food & Drug Administration (FDA) today...


Jun 25, 2019, 08:00 ET TB Alliance Names Eugene Sun as Senior Vice President for Research and Development

TB Alliance today announced the appointment of Eugene Sun, MD to the position of Senior Vice President for Research and Development. Dr. Sun will...


Jun 12, 2019, 08:00 ET Mitchell Warren Elected President of TB Alliance Stakeholders Association, Joins Board of Directors

TB Alliance, a not-for-profit organization leading the development of new, improved and affordable tuberculosis (TB) treatments, today announced that ...


Jun 06, 2019, 20:00 ET FDA Advisory Committee Votes Favorably on the Question of the Effectiveness and Safety of Pretomanid in Combination with Bedaquiline and Linezolid for Treatment of Highly Drug-Resistant Forms of Tuberculosis

TB Alliance announced today that the U.S. Food and Drug Administration (FDA) Antimicrobial Drugs Advisory Committee voted (14 yes, 4 no, 0 abstain)...


Jan 15, 2019, 08:00 ET Jan Lundberg Joins TB Alliance Board of Directors

TB Alliance, a not-for-profit organization dedicated to developing new drug regimens to fight tuberculosis (TB), has appointed Dr. Jan Lundberg to...


Jul 13, 2018, 13:06 ET TB Alliance Names Angela Vanderploeg as Chief Financial Officer

TB Alliance today announced the appointment of Angela Vanderploeg as Chief Financial Officer. Ms. Vanderploeg joins TB Alliance most recently from...


Mar 06, 2018, 09:00 ET Nancy Miller-Rich Joins TB Alliance Board of Directors

TB Alliance, a not-for-profit organization dedicated to finding faster-acting and affordable drug regimens to fight tuberculosis (TB), has appointed...


Nov 06, 2017, 08:00 ET TB Alliance Welcomes Ariel Pablos-Méndez to Its Board of Directors

TB Alliance today announced the appointment of Dr. Ariel Pablos-Méndez to its board of directors. As a physician and a leader in global public...


Dec 02, 2015, 02:01 ET TB Alliance and Partners Announce World's First Availability of Appropriate, Child-friendly TB Medicines in Correct Doses

TB Alliance and its partners announced today the availability of child-friendly tuberculosis (TB) medicines in the correct doses. The improved...


May 13, 2015, 08:00 ET TB Alliance startet die klinische Studie „Nix-TB" als Test einer neuen Therapie gegen hochresistente TB

TB Alliance und seine Partner kündigen den Start einer klinischen Studie eines neuen Therapieansatzes zur Behandlung von äußerst...


May 13, 2015, 08:00 ET TB Alliance Launches "Nix-TB" Clinical Trial to Test New XDR-TB Treatment

TB Alliance and its partners announced the start of a clinical trial of a new regimen to treat extensively drug-resistant tuberculosis (XDR-TB.) It...


Mar 24, 2015, 08:00 ET TB Alliance Announces Partnership with U.S. Fund for UNICEF to Increase Access to Impending New Child-Friendly TB Treatments

TB Alliance has announced a new partnership with the U.S. Fund for UNICEF that will dramatically increase the scope and impact of child and maternal...


Mar 24, 2015, 03:00 ET Australia Grants Support for TB Alliance to Advance New TB Drugs

TB Alliance, a not-for-profit product development partnership with the mission of developing better, faster, and affordable drugs for tuberculosis...


Mar 17, 2015, 08:01 ET The Lancet: Resultaten fase 2b onderzoek wijzen uit dat nieuw middel PaMZ de behandeling van tbc kan verkorten en verbeteren

Een nieuwe medicijncombinatie tegen tuberculose (tbc), ontwikkeld om de mogelijkheden voor de behandeling van tbc te vergroten, doodt méér bacteriën...


Feb 18, 2015, 07:01 ET TB Alliance Advances Next-Generation TB Drug Candidate into Clinical Testing

TB Alliance has announced the start of the first human trial of a new tuberculosis (TB) drug candidate, designated TBA-354. It is the first new TB...


Jan 13, 2015, 12:30 ET TB Alliance Announces Two New Members to its Board of Directors: Dr. Mario Raviglione of WHO and Shalini Sharp of Ultragenyx

TB Alliance, an international not-for-profit organization with the mission of developing improved tuberculosis (TB) treatments, announced the...


Jul 31, 2014, 09:05 ET TB Alliance Names Elana Robertson Senior Vice President, Market Access

TB Alliance, a not-for-profit organization with the mission of developing better, faster and affordable treatments for tuberculosis (TB), announced...


Jul 31, 2014, 09:05 ET TB Alliance Appoints Willo Brock Senior Vice President, External Affairs

TB Alliance, a not-for-profit with the mission of discovering and developing better, faster and affordable treatments, announced the appointment of...


May 14, 2014, 09:05 ET TB Alliance Appoints Dr. Nader Fotouhi, Chief Scientific Officer

TB Alliance, a not-for-profit organization dedicated to developing better, faster, and affordable treatments for tuberculosis (TB), announced the...


Apr 23, 2014, 02:30 ET New Tuberculosis Drug Regimen Will Move to Landmark Phase 3 Clinical Trial

Based on positive results from earlier clinical studies, TB Alliance is advancing the first-ever drug regimen designed to treat both drug-sensitive...


Apr 23, 2014, 02:30 ET TB Alliance Grants Fosun Pharma Rights to Develop, Market Promising TB Cure in China

TB Alliance, an international non-profit drug development organization that develops better, faster-acting, and affordable tuberculosis (TB) drugs,...


Apr 23, 2014, 02:30 ET Neue Tuberkulose-Kombinationstherapie erreicht wegweisende Phase III-Studie

Auf Grundlage positiver Ergebnisse früherer klinischer Phasen erreicht die erste Kombinationstherapie, die für die Behandlung medikamentensensitiver...


May 28, 2013, 02:00 ET Debrework Zewdie Appointed to TB Alliance's Board of Directors

TB Alliance, a not-for-profit organization with the mission of developing better, faster-acting, and affordable TB treatments, announces the election ...


Feb 25, 2013, 09:33 ET PSI CEO Karl Hofmann Elected President of TB Alliance's Stakeholders Association, Joins Board of Directors

TB Alliance, a not-for-profit organization with the mission of developing new, improved, and affordable TB treatments, announces the election of Karl ...